S1-Guideline for Diagnosis and Treatment of Erectile Dysfunction

被引：4

作者：

Haensch, Carl-Albrecht ^{[1
]}

Hilz, Max ^{[2
]}

Jost, Wolfgang ^{[3
]}

Kaufmann, Albert ^{[4
]}

Kessler, Thomas ^{[5
]}

Lahrmann, Heinz

机构：

[1] Kliniken Maria Hilf, Klin Neurol, Viersenerstr 450, D-41063 Monchengladbach, Germany

[2] Univ Erlangen Nurnberg, Klin Neurol, Erlangen, Germany

[3] Parkinson Klin, PKW, Wolfach, Germany

[4] Kliniken Maria Hilf, Zentrum Kontinenz & Neurourol, Monchengladbach, Germany

[5] Univ Balgrist, Zentrum Paraplegie, Zurich, Switzerland

来源：

FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE | 2019年 / 87卷 / 04期

关键词：

Erectile dysfunction; PDE-5; inhibitors; Sexual activity; SEXUAL DYSFUNCTION; INTERNATIONAL INDEX; ORAL SILDENAFIL; CARDIAC RISK; MG; EFFICACY; VARDENAFIL; GUIDELINES; MEN; EPIDEMIOLOGY;

D O I：

10.1055/a-0747-5892

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The S1-Guideline Diagnosis and Therapy of Erectile Dysfunction (Association of the Scientific Medical Societies in Germany (AWMF) registration number 030/112) is available in a completely revised version. Erectile dysfunction (ED) is defined as the persistent or recurrent inability to acquire or sustain an erection of sufficient rigidity and duration for sexual intercourse. There is a high prevalence of ED in the general population in Germany. The frequency of sexual activity decreases with age, and sexual problems become more common with aging. Overall, the prevalence of ED is 2.3% in men 20 to 30 years of age and 53.4% in men in their 7th decade of life. The guideline offers firm recommendations for the diagnosis and treatment of patients suffering from ED. The introduction of new oral therapies has completely changed the diagnostic and therapeutic approach to ED, which is often carried out in a uncritical way.

引用

页码：225 / 233

页数：9

共 52 条

[1]

Angulo J, 2001, INT J IMP RES, V13, P64

[2] THE USE OF CONVENTIONAL ELECTROMYOGRAPHY TO ASSESS EXTERNAL SPHINCTER NEUROPATHY IN MAN [J].

BARTOLO, DCC ;

JARRATT, JA ;

READ, NW .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1983, 46 (12) :1115-1118

[3] Evaluation and medical management of erectile dysfunction [J].

Beckman, TJ ;

Abu-Lebdeh, HS ;

Mynderse, LA .

MAYO CLINIC PROCEEDINGS, 2006, 81 (03) :385-390

[4] A conscious-rabbit model to study vardenafil hydrochloride and other agents that influence penile erection [J].

Bischoff, E ;

Schneider, K .

INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2001, 13 (04) :230-235

[5] Sildenafil, a novel effective oral therapy for male erectile dysfunction [J].

Boolell, M ;

GepiAttee, S ;

Gingell, JC ;

Allen, MJ .

BRITISH JOURNAL OF UROLOGY, 1996, 78 (02) :257-261

[6] Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey' [J].

Braun, M ;

Wassmer, G ;

Klotz, T ;

Reifenrath, B ;

Mathers, M ;

Engelmann, U .

INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2000, 12 (06) :305-311

[7] The conditioned response erection (CRE) - a new approach to modelling erectile responses in the rat [J].

Brien, SE ;

Wilson, E ;

Heaton, JPW ;

Adams, MA .

INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2000, 12 (02) :91-96

[8]

Brock G, 2002, EUR UROL SL, P152

[9] Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses [J].

Brock, GB ;

McMahon, CG ;

Chen, KK ;

Costigan, T ;

Shen, W ;

Watkins, V ;

Anglin, G ;

Whitaker, S .

JOURNAL OF UROLOGY, 2002, 168 (04) :1332-1336

[10]

Buddeberg C, 1996, SEXUALBERATUNG

← 1 2 3 4 5 6 →